Welch Allyn and EarlySense Announce Strategic Collaboration Agreement

  Welch Allyn and EarlySense Announce Strategic Collaboration Agreement

       Welch Allyn to distribute EarlySense System in the United States

Business Wire

SKANEATELES, N.Y. & WALTHAM, Mass. -- January 30, 2013

Welch Allyn, a leading medical diagnostic device company that specializes in
helping clinicians improve patient outcomes, and EarlySense Ltd., the market
leader in Proactive Patient Care Solutions™, announced today that the
companies have entered into a strategic collaboration and distribution
agreement. Under the terms of the agreement, Welch Allyn will distribute the
EarlySense System to hospitals across the United States.

The EarlySense System offers clinicians the ability to identify early warning
signs of patient safety risk and deterioration, thus empowering clinicians to
achieve better outcomes and fewer adverse events. Without ever physically
touching the patient, the system measures heart rate, respiration rate,
patient movement while in bed, and patient bed entries and exits, using a
sensor that is placed under the mattress of a bed.

Welch Allyn President & CEO Steve Meyer said, “EarlySense technology assists
clinicians in early detection of patient deterioration to help medical teams
save lives and reduce costs. The opportunity to partner with EarlySense
enables Welch Allyn to continue providing its customers with proven solutions
that answer the growing clinical, economic and regulatory needs to reduce
adverse clinical events and improve patient safety. We view this relationship
as an important advancement that brings better, more cost-effective care to
previously unmonitored beds.”

The EarlySense technology is designed to monitor patients on medical surgical
floors who typically have their vital signs taken only once every four hours.
In the event of a change in a patient’s status, the system immediately and
simultaneously provides alerts to the clinical staff via the bedside monitor,
the central nursing station, hallway displays, and directly to their pagers or
in-house telephones.

EarlySense CEO Avner Halperin said, “It is an exciting day for all EarlySense
employees and shareholders. For nearly 100 years Welch Allyn has been
providing innovative solutions that advance frontline patient care. As a
leading patient vital signs solutions provider within the medical /surgical
floors of hospitals across the United States, we believe our work with Welch
Allyn will accelerate adoption of EarlySense’s technology. Welch Allyn has a
tremendous reputation in the US Healthcare markets. EarlySense’s technology
and expertise in systems-based products and solutions coupled with Welch
Allyn’s sales, marketing, implementation and support strength, puts
EarlySense’s contact-free patient monitoring solution on a clear path to
becoming the standard of care, giving medical teams the tools to improve
outcomes, prevent adverse events and leave no patients behind. Together, Welch
Allyn and EarlySense are targeting more than one million acute care beds that
clinicians widely agree can be made much safer with smart, continuous
monitoring.”

About Welch Allyn

Welch Allyn is a leading global healthcare company that offers a complete
range of digital and EMR-interfaced diagnostic solutions, physical diagnosis
instruments, and infection control products that help reduce risk and enhance
workflow in a variety of clinical settings. Founded in 1915 and headquartered
in Skaneateles Falls, N.Y. (USA), Welch Allyn is a family-owned business that
employs nearly 2,700 employees in 26 different countries. The company
specializes in helping doctors, nurses and other frontline practitioners
across the globe enhance care by developing innovative solutions that improve
patient outcomes, safety and satisfaction. More information about Welch Allyn
and its complete line of connected products and solutions may be found at
www.welchallyn.com. Like us onFacebookand follow us onTwitter.

About EarlySense

EarlySense has brought to market an innovative technology designed to advance
proactive patient care and enable clinicians to achieve better patient
outcomes, by assisting in preventing adverse events from occurring. The
company’s flagship product, the EarlySense System, is a continuous,
contact-free, patient monitoring solution that monitors and documents a
patient’s vital signs and movement using a sensor that is placed underneath a
bed mattress. There are no leads or cuffs to connect to the patient who has
complete freedom of movement and is not burdened by any cumbersome
attachments. The system is designed to monitor non-ICU ‘lower risk’ patients
on medical surgical floors who are usually monitored by nursing staff
approximately once every four hours. The system is currently installed at
hospitals and rehabilitation centers in the USA and Europe. It is also
commercially available in Canada. EarlySense Inc. is headquartered in Waltham,
MA. Investors include: JK&B, Pitango Venture Capital, Etgar Challenge Fund,
ProSeed VC Fund (TASE: PRSD), Docor International Management, Noaber, and
Bridge Investment Fund, and Peter Soderberg, managing partner of Worthy
Ventures Resources, LLC and former president and CEO of Hill-Rom Holdings,
Inc. (NYSE: HRC). For additional information, please visit www.earlysense.com.
Follow us on Twitter and like us on Facebook.

Contact:

Welch Allyn
Jamie Arnold, APR, 315-685-4599
Public Relations Manager
jamie.arnold@welchallyn.com
or
EarlySense
Marjie Hadad, 617-939-9514
Media Liaison
marjie.hadad@earlysense.com
 
Press spacebar to pause and continue. Press esc to stop.